Hungary vs South Asia: Immunization, Hib3
Hungary
99.0%
in 2024
South Asia
94.5%
in 2024
Hungary rank
1st
South Asia rank
1st
Immunization, Hib3 over time
- Hungary
- South Asia
How they compare
Hungary currently reports 99.0% against 94.5% in South Asia, a difference of 4.5%.
Across all 26 years both countries report, Hungary has been ahead every year.
Hungary ranks 1st and South Asia ranks 1st of 191 countries.
Hungary has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Hungary | South Asia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 99.0% | 0.0% | 99.0% | Hungary |
| 2000s | 99.0% | 1.1% | 97.9% | Hungary |
| 2010s | 99.0% | 50.6% | 48.4% | Hungary |
| 2020s | 99.0% | 90.6% | 8.4% | Hungary |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Hungary or South Asia?
- Hungary, at 99.0% against 94.5% in South Asia as of 2024.
- What is the difference in immunization, hib3 between Hungary and South Asia?
- 4.5%, with Hungary ahead.
- How many years of comparable data are there for Hungary and South Asia?
- 26 years are reported by both, from 1999 to 2024.
- How do Hungary and South Asia rank globally for immunization, hib3?
- Hungary ranks 1st and South Asia ranks 1st of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.